Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06637852 · ClinicalTrials.gov registry record · NA
Sexual and Urinary Function Improvement for Cancer Survivors
A NA study, sponsored by NYU Langone Health.
- Not yet
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT06637852 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 200 participants.
The verdict
NCT06637852, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy of SUFICS-PACT to identify and treat sexual and urinary dysfunction in prostate cancer survivors at NYC H+ H/Bellevue, the oldest public hospital in the US. This study will evaluate the implementation of an adapted sexual and urinary function collaborative care model at NYC Health+Hospitals/Bellevue. The study will test the efficacy of this collaborative care model through a randomized controlled trial in the adult primary care clinic; the intervention arm will receive collaborative treatment consisting of a care manager who has specialty training in mental health and psychosexual counseling, a primary care nurse practitioner who leads symptom management, primary care physicians who supervise the team, and a team specialty consult liaison.
Interventions
- BEHAVIORAL SUFICS-PACT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2030-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06637852
The ClinicalTrials.gov registry entry for NCT06637852 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SUFICS-PACT is the first listed.
NCT06637852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06637852 about?
NCT06637852 is a clinical study titled "Sexual and Urinary Function Improvement for Cancer Survivors". The purpose of this study is to test the efficacy of SUFICS-PACT to identify and treat sexual and urinary dysfunction in prostate cancer survivors at NYC H+ H/Bellevue, the oldest public hospital in the US. This study will evaluate the implementation of an adapted sexual and urinary function collabo...
What is the current status of trial NCT06637852?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-10-01. Estimated completion is 2030-03-31.
What interventions are being tested in trial NCT06637852?
The interventions under investigation include: SUFICS-PACT (BEHAVIORAL).
Who is sponsoring clinical trial NCT06637852?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.